This is a snippet of the transcript.Contact Salesto get full access.
You have several competing factors in a warehouse. You have warehouse space efficiency, productivity, and flex capacity, the ability to ramp up and ramp down. For instance, at Christmas time, in e-tail centers, a warehouse might be very space efficient and productive, but if you can't surge an extra 200 people in there to handle Christmas volumes, then you get handcuffed. Right now, there is so much technology out there, so evaluating the right technology that makes sense, that's flexible, that's scalable, that doesn't eat up a ton of space, is critically important. You need to make the right decisions, not just get robots into a warehouse because it looks good.
This is a snippet of the transcript.Contact Salesto get full access.
What prompted this change was a leader within Novartis who recognized they weren't very good at supply chain management. They were spending a lot of money on warehouses that were in the wrong locations. As they grew, their operations became over-engineered and inefficient. This leader knew they needed a professional supply chain partner and trusted us because we were committed to the space. He trusted that we had the ability to operate and understood our commitment to distributing life-saving drugs.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.